Quantitative determination of sst2 and sst5 gene expression in uterine leiomyomata and the effect of treatment with somatostatin analogue.
De Leo
Vincenzo
V
La Marca
Antonio
A
Vegni
Virginia
V
Raggi
Claudia Casini
CC
Maggi
Mario
M
Petraglia
Felice
F
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D020690:GTPase-Activating Proteins / Q000235:genetics / Q000378:metabolism*; D015870:Gene Expression; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy / Q000235:genetics*; D008875:Middle Aged; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D017481:Receptors, Somatostatin / Q000235:genetics / Q000378:metabolism*; D029701:Saccharomyces cerevisiae Proteins / Q000235:genetics / Q000378:metabolism*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D020710:RGS Proteins
D000970:Antineoplastic Agents; D020690:GTPase-Activating Proteins; D010456:Peptides, Cyclic; D017481:Receptors, Somatostatin; D029701:Saccharomyces cerevisiae Proteins; D013004:Somatostatin; C094301:SST2 protein, S cerevisiae; D020710:RGS Proteins; C060347:lanreotide; C094573:somatostatin receptor 5